Disclosure Information

  • Daniel G Hoernschemeyer, MD, FAAOS

    Submitted on: 04/28/2022
    Biomarin: Paid presenter or speaker; Research support
    Orthopediatrics: IP royalties; Paid consultant; Stock or stock Options